Sub: Intimation of Schedule of Analyst / Institutional Investor Meeting
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find below the schedule of Analyst/ Institutional Investor Meetings with the Company:
Date
Institution Name
Type of Meeting
28th October 2022
Motilal Oswal Mutual Fund
Virtual - One on One Call
Klay Capital
The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company.
This is for your information and records.
Yours truly,
For Gland Pharma Limited
SAMPATH
KUMAR
PALLERLAMUDI
Digitally signed by SAMPATH KUMAR PALLERLAMUDI DN: cn=SAMPATH KUMAR PALLERLAMUDI, c=IN, o=Personal, email=sampath@glandpharma.com Date: 2022.10.28 09:08:39 +05'30'
P Sampath Kumar
Company Secretary and Compliance Officer
Attachments
Original Link
Original Document
Permalink
Disclaimer
Gland Pharma Ltd. published this content on 28 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 October 2022 04:02:02 UTC.
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.
GLAND PHARMA LIMITED 
